Flash FinanceUS
Market closed S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · The Vita Coco (COCO)

Vita Coco Q3 net sales rise 34% to $244 million; full-year guidance raised

Positive Impact 4 of 5 guidance

Vita Coco reported third-quarter 2026 net sales of $244 million, up 34% from a year earlier, and net income of $35 million, or $0.58 per diluted share, compared with $24 million, or $0.40, a year earlier. The company raised its full-year 2026 net sales guidance to $810 million to $820 million and adjusted EBITDA guidance to $170 million to $175 million, with growth partly driven by the Copra acquisition completed in July 2026.

Key points

  • Q3 2026 net sales of $244 million, up $62 million or 34%; organic net sales growth was 18%
  • Q3 net income of $35 million ($0.58 per diluted share) versus $24 million ($0.40) a year earlier
  • Full-year 2026 net sales guidance raised to $810 million to $820 million from $790 million to $805 million; adjusted EBITDA guidance raised to $170 million to $175 million from $154 million to $161 million
  • Fourth-quarter gross margin is expected to be approximately 33%, and cash fell to $152 million at September 30, 2026 after the $139 million Copra payment

The filing

CompanyThe Vita Coco (COCO)
Form8-K, current report
Filed with the SECOct 22, 2026, 7:32 AM ET
Accession number0001482981-26-000183

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 7, 2026, 11:17 PM ET, from this filing only.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.